Latest press releases

AMS experiment embarks on first leg of mission into space

Geneva, 12 February 2010. The Alpha Magnetic Spectrometer (AMS) left CERN1 this morning on the first leg of its journey to the International Space Station (ISS). A special convoy carrying the experiment is due to arrive at the European Space Agency's research and technology centre, ESTEC, at Noordwijk in the Netherlands in six days time. Once there, the detector will undergo testing of its ability to survive a shuttle lift-off and to operate in space. Twenty members of the AMS collaboration will accompany the detector on its journey.

LHC ends 2009 run on a high note

Geneva, 18 December 2009. At its 153rd session today, the CERN1 Council heard that the Large Hadron Collider ended its first full period of operation in style on Wednesday 16 December. Collisions at 2.36TeV recorded since last weekend have set a new world record and brought to a close a successful first run for the world’s most powerful particle accelerator. The LHC has now been put into standby mode, and will restart in February 2010 following a short technical stop to prepare for higher energy collisions and the start of the main research programme.

LHC ends 2009 run on a high note

Geneva, 18 December 2009. At its 153rd session today, the CERN1 Council heard that the Large Hadron Collider ended its first full period of operation in style on Wednesday 16 December. Collisions at 2.36TeV recorded since last weekend have set a new world record and brought to a close a successful first run for the world’s most powerful particle accelerator. The LHC has now been put into standby mode, and will restart in February 2010 following a short technical stop to prepare for higher energy collisions and the start of the main research programme.

CERN Colour X-ray Technology Set to Save Lives

Geneva, 14 December 2009 Medical studies are soon to start with the MARS scanner, a revolutionary CT scanner developed by the University of Canterbury1, New Zealand. The scanner, which incorporates technology developed at the world’s leading particle physics research centre, CERN2, was recently shipped to research partners in North America. Today a student from Canterbury arrives in North America to use the scanner to study heart disease. This development puts the technology, known as Medipix3, firmly on the path to saving lives.

Pages

Subscribe to Latest press releases

You are here